Evidence map›Paper›PMID 23499446›Full record

ArticleCell reports2013

Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.

Nicola Ternette, Ming Yang, Mahima Laroyia, Mitsuhiro Kitagawa, Linda O'Flaherty, Kathryn Wolhulter, Kaori Igarashi, Kaori Saito, Keiko Kato, Roman Fischer and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 156 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Cysteine-S-nitrosylation inhibits Rop5-mediated immune evasion inbioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Adenylosuccinic Acid: An Orphan Drug with Untapped Potential.Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Nicola TernetteCentral Proteomics Facility, Henry Wellcome Building for Molecular Physiology, University of Oxford, Oxford OX3 7BN, UK.
Ming Yang
Mahima Laroyia
Mitsuhiro Kitagawa
Linda O'Flaherty
Kathryn Wolhulter
Kaori Igarashi
Kaori Saito
Keiko Kato
Roman Fischer
Alexandre Berquand
Benedikt M Kessler
Terry Lappin
Norma Frizzell
Tomoyoshi Soga
Julie Adam
Patrick J Pollard
University of Oxford · GBKeio University · JPBruker (Germany) · DEQueen's University Belfast · GBUniversity of South Carolina · US

Funding

Cancer Research UK 13349Cancer Research UK A12027Cancer Research UK A13349Cancer Research UK A14607European Research Council 310837Wellcome TrustWellcome Trust WT091112MA
6 · The paper itself

Abstract

The gene encoding the Krebs cycle enzyme fumarate hydratase (FH) is mutated in hereditary leiomyomatosis and renal cell cancer (HLRCC). Loss of FH activity causes accumulation of intracellular fumarate, which can directly modify cysteine residues to form 2-succinocysteine through succination. We undertook a proteomic-based screen in cells and renal cysts from Fh1 (murine FH)-deficient mice and identified 94 protein succination targets. Notably, we identified the succination of three cysteine residues in mitochondrial Aconitase2 (ACO2) crucial for iron-sulfur cluster binding. We show that fumarate exerts a dose-dependent inhibition of ACO2 activity, which correlates with increased succination as determined by mass spectrometry, possibly by interfering with iron chelation. Importantly, we show that aconitase activity is impaired in FH-deficient cells. Our data provide evidence that succination, resulting from FH deficiency, targets and potentially alters the function of multiple proteins and may contribute to the dysregulated metabolism observed in HLRCC.

Indexed as

Aconitate HydrataseAnimalsCell LineCysteineFumarate HydrataseFumaratesHumansIronKidney NeoplasmsLeiomyomatosisMiceMice, TransgenicMitochondriaNeoplastic Syndromes, HereditaryProteomeSkin NeoplasmsACO2 protein, humanAconitate HydrataseCysteineFumarate HydrataseFumaratesfumaric acidIronProteomeSuccinic Acid

Identifiers

PMID23499446
PMCPMC3617368
OpenAlexW2134983570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.